BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Field K, Lipton L. Metastatic colorectal cancer-past, progress and future. World J Gastroenterol 2007; 13(28): 3806-3815 [PMID: 17657834 DOI: 10.3748/wjg.v13.i28.3806]
URL: https://www.wjgnet.com/1007-9327/full/v13/i28/3806.htm
Number Citing Articles
1
Francis Park-Yun Cheung, Naveed Zeb Alam, Gavin Michael Wright. The Past, Present and Future of Pulmonary Metastasectomy: A Review ArticleAnnals of Thoracic and Cardiovascular Surgery 2019; 25(3): 129 doi: 10.5761/atcs.ra.18-00229
2
Woo-Jeong Jeong, Pu-Hyeon Cha, Kang-Yell Choi. Strategies to overcome resistance to epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancerWorld Journal of Gastroenterology 2014; 20(29): 9862-9871 doi: 10.3748/wjg.v20.i29.9862
3
Sadaf Qureshi, Lyudmyla Berim, Patrick M. Boland. Current Treatment Landscape for Third- or Later-Line Therapy in Metastatic Colorectal CancerCurrent Colorectal Cancer Reports 2021;  doi: 10.1007/s11888-021-00469-4
4
Omar Castillo-Fernández, Miguel Santibáñez, Aldo Bauza, Germán Calderillo, Clementina Castro, Roberto Herrera, Alberto Serrano, Oscar Arrieta, Luis A. Herrera. Methylenetetrahydrofolate Reductase Polymorphism (677 C>T) Predicts Long Time to Progression in Metastatic Colon Cancer Treated with 5-Fluorouracil and Folinic AcidArchives of Medical Research 2010; 41(6): 430 doi: 10.1016/j.arcmed.2010.08.011
5
Ning Wang, Liyi Zeng, Zhaoxia Li, Yanfang Zhen, Huoming Chen. Serum miR-663 expression and the diagnostic value in colorectal cancerArtificial Cells, Nanomedicine, and Biotechnology 2019; 47(1): 2650 doi: 10.1080/21691401.2019.1628036
6
Yoko Tomita, Christos S. Karapetis, Shahid Ullah, Amanda R. Townsend, David Roder, Carol Beeke, Amitesh C. Roy, Rob Padbury, Timothy J. Price. Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registryActa Oncologica 2016; 55(4): 480 doi: 10.3109/0284186X.2015.1117135
7
Łukasz Pietrzyk, Paulina Wdowiak. Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patientsAdvances in Medical Sciences 2019; 64(2): 402 doi: 10.1016/j.advms.2019.07.001
8
Xing‐Hua Liang, Guang‐Xian Zhang, Yue‐bin Zeng, Hai‐Feng Yang, Wen‐Hong Li, Qi‐Long Liu, Yue‐liang Tang, Wen‐guang He, Yan‐Nian Huang, Lei Zhang, Li‐Na Yu, Xian‐Cheng Zeng. LIM protein JUB promotes epithelial–mesenchymal transition in colorectal cancer Cancer Science 2014; 105(6): 660 doi: 10.1111/cas.12404
9
Elena A. Pudova, Anna V. Kudryavtseva, Maria S. Fedorova, Andrew R. Zaretsky, Dmitry S. Shcherbo, Elena N. Lukyanova, Anatoly Y. Popov, Asiya F. Sadritdinova, Ivan S. Abramov, Sergey L. Kharitonov, George S. Krasnov, Kseniya M. Klimina, Nadezhda V. Koroban, Nadezhda N. Volchenko, Kirill M. Nyushko, Nataliya V. Melnikova, Maria A. Chernichenko, Dmitry V. Sidorov, Boris Y. Alekseev, Marina V. Kiseleva, Andrey D. Kaprin, Alexey A. Dmitriev, Anastasiya V. Snezhkina. HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancerBMC Genomics 2018; 19(S3) doi: 10.1186/s12864-018-4477-4
10
Duthika M. Mallawaaratchy, Swetlana Mactier, Kimberley L. Kaufman, Katherine Blomfield, Richard I. Christopherson. The phosphoinositide 3-kinase inhibitor LY294002, decreases aminoacyl-tRNA synthetases, chaperones and glycolytic enzymes in human HT-29 colorectal cancer cellsJournal of Proteomics 2012; 75(5): 1590 doi: 10.1016/j.jprot.2011.11.032
11
Kimmie Ng, Josep Tabernero, Jimmy Hwang, Emilio Bajetta, Sunil Sharma, Salvatore A. Del Prete, Edward R. Arrowsmith, David P. Ryan, Michaela Sedova, Jin Jin, Kamel Malek, Charles S. Fuchs. Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based RegimensClinical Cancer Research 2013; 19(14): 3987 doi: 10.1158/1078-0432.CCR-13-0027
12
Li-Jun Wang, Zhong-Yi Zhang, Xiao-Luan Yan, Wei Yang, Kun Yan, Bao-Cai Xing. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysisWorld Journal of Surgical Oncology 2018; 16(1) doi: 10.1186/s12957-018-1494-3
13
Kaitlyn J Kelly, Joyce Wong, Yuman Fong. Herpes simplex virus NV1020 as a novel and promising therapy for hepatic malignancyExpert Opinion on Investigational Drugs 2008; 17(7): 1105 doi: 10.1517/13543784.17.7.1105
14
Alessandra Silvestri, Valerie Calvert, Claudio Belluco, Michael Lipsky, Ruggero De Maria, Jianghong Deng, Alfonso Colombatti, Francesco De Marchi, Donato Nitti, Enzo Mammano, Lance Liotta, Emanuel Petricoin, Mariaelena Pierobon. Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterationsClinical & Experimental Metastasis 2013; 30(3): 309 doi: 10.1007/s10585-012-9538-5
15
G. G. Khakimova, A. A. Tryakin, T. N. Zabotina, A. S. Tsukanov, V. A. Aliev, S. L. Gutorov. The Role of the Intestinal Microbiome in the Immunotherapy of Colon CancerMalignant tumours 2019; 9(2): 5 doi: 10.18027/2224-5057-2019-9-2-5-11
16
Alfonso De Stefano, Chiara Carlomagno. Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancerWorld Journal of Gastroenterology 2014; 20(29): 9732-9743 doi: 10.3748/wjg.v20.i29.9732
17
Seyed Khalil Rashidi, Seyed Latif Mousavi Gargari, Walead Ebrahimizadeh. Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential TargetIranian Journal of Biotechnology 2017; 15(2): 78 doi: 10.15171/ijb.1472
18
Xiaochuan Liu, Yunxiang Chu, Dongsheng Wang, Yan Weng, Zhiwei Jia. MAPK‐mediated upregulation of fibrinogen‐like protein 2 promotes proliferation, migration, and invasion of colorectal cancer cellsCell Biology International 2019; 43(12): 1483 doi: 10.1002/cbin.11198
19
Ellen G. Engelhardt, Dóra Révész, Hans J. Tamminga, Cornelis J.A. Punt, Mirjam Koopman, Bregje D. Onwuteaka-Philipsen, Ewout W. Steyerberg, Ilse P. Jansma, Henrica C.W. De Vet, Veerle M.H. Coupé. Clinical Usefulness of Tools to Support Decision-making for Palliative Treatment of Metastatic Colorectal Cancer: A Systematic ReviewClinical Colorectal Cancer 2018; 17(1): e1 doi: 10.1016/j.clcc.2017.06.007
20
Nele Boeckx, Ken Op de Beeck, Vanessa Deschoolmeester, Guy Van Camp, Patrick Pauwels, Marc Peeters. Anti-EGFR Resistance in Colorectal Cancer: Current Knowledge and Future PerspectivesCurrent Colorectal Cancer Reports 2014; 10(4): 380 doi: 10.1007/s11888-014-0242-5
21
Tai-Lin Chen, Yi-Wen Lin, Yan-Bo Chen, Jing-Jer Lin, Tsann-Long Su, Chia-Ning Shen, Te-Chang Lee. A Low-Toxicity DNA-Alkylating N-Mustard-Quinoline Conjugate with Preferential Sequence Specificity Exerts Potent Antitumor Activity Against Colorectal CancerNeoplasia 2018; 20(2): 119 doi: 10.1016/j.neo.2017.11.006
22
JaeIn Park, Jae-Hyun Jang, Jae-Hong Kim. Mediatory role of BLT2 in the proliferation of KRAS mutant colorectal cancer cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research 2019; 1866(3): 329 doi: 10.1016/j.bbamcr.2018.12.006
23
A. Silvestri, E. Pin, A. Huijbers, R. Pellicani, E. M. Parasido, M. Pierobon, E. Petricoin, L. Liotta, C. Belluco. Individualized therapy for metastatic colorectal cancerJournal of Internal Medicine 2013; 274(1): 1 doi: 10.1111/joim.12070
24
Nedyalka Zgurova, Krasimira Prodanova, Maria Tzaneva, Janko Stefanov. Prognostic factors for the presence of the methastasis in lymph nodes and organs in Bulgarien patients with colorectal carcinoma2018; 2048: 020014 doi: 10.1063/1.5082032
25
Nasrin Sarafan-Vasseur, David Sefrioui, David Tougeron, Aude Lamy, France Blanchard, Florence Le Pessot, Frédéric Di Fiore, Pierre Michel, Stéphane Bézieau, Jean-Baptiste Latouche, Thierry Frebourg, Richard Sesboüé. Genetic variations of the A13/A14 repeat located within the EGFR3′ untranslated region have no oncogenic effect in patients with colorectal cancerBMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-183
26
S.D. Richman, G.G.A. Hutchins, M.T. Seymour, P. Quirke. What can the molecular pathologist offer for optimal decision making?Annals of Oncology 2010; 21: vii123 doi: 10.1093/annonc/mdq379
27
Ghodratollah Roshanaei, Malihe Safari, Javad Faradmal, Mohammad Abbasi, Salman Khazaei. Factors affecting the survival of patients with colorectal cancer using random survival forestJournal of Gastrointestinal Cancer 2020;  doi: 10.1007/s12029-020-00544-3
28
Ioannis D. Xynos, Nicolaos Kavantzas, Smaro Tsaousi, Michalis Zacharakis, George Agrogiannis, Christos Kosmas, Andreas Lazaris, John Sarantonis, Stavros Sougioultzis, Dimitrios Tzivras, Aris Polyzos, Efstratios S. Patsouris, Nikolas Tsavaris. Factors Influencing Survival in Stage IV Colorectal Cancer: The Influence of DNA PloidyISRN Gastroenterology 2013; 2013: 1 doi: 10.1155/2013/490578
29
Silke Cameron, Diana Hünerbein, Tümen Mansuroglu, Thomas Armbrust, Jens-Gerd Scharf, Harald Schwörer, László Füzesi, Giuliano Ramadori. Response of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapyBMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-218
30
Jesús García-Foncillas, Eduardo Díaz-Rubio. Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcomeClinical and Translational Oncology 2010; 12(8): 533 doi: 10.1007/s12094-010-0551-3
31
Chenbo Ding, Longmei Li, Taoyu Yang, Xiaobo Fan, Guoqiu Wu. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice modelBMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2834-8
32
Qiuji Wu, Pengfei Zhang, Xinyuan Wang, Mengxi Zhang, Weiting Liao, Qiu Li. Cost-effectiveness of Capecitabine + Irinotecan Versus Leucovorin + Fluorouracil + Irinotecan in the Second-line Treatment of Metastatic Colorectal Cancer in ChinaClinical Therapeutics 2020; 42(11): 2148 doi: 10.1016/j.clinthera.2020.08.015
33
Fabian Frank, Markus Hecht, Florian Loy, Sandra Rutzner, Rainer Fietkau, Luitpold Distel. Differences in and Prognostic Value of Quality of Life Data in Rectal Cancer Patients with and without Distant MetastasesHealthcare 2020; 9(1): 1 doi: 10.3390/healthcare9010001
34
Dinuk Goonerante, Chris Gray, Michael Lim, Liane Dixon, Bruce Dobbs, Chris Wakeman, Frank Frizelle. Survival outcome in New Zealand after resection of colorectal cancer lung metastasesANZ Journal of Surgery 2013; 83(12): 959 doi: 10.1111/ans.12012
35
T Matsumura, K Sugimachi, H Iinuma, Y Takahashi, J Kurashige, G Sawada, M Ueda, R Uchi, H Ueo, Y Takano, Y Shinden, H Eguchi, H Yamamoto, Y Doki, M Mori, T Ochiya, K Mimori. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancerBritish Journal of Cancer 2015; 113(2): 275 doi: 10.1038/bjc.2015.201
36
Md Shuayb, Md Mehedi Hasan, Md Rashedul Hoque, Qazi Mushtaq Hussain, Rabeya Begum, Md Salim Reza. Survival and prognostic association in stage IV colorectal cancer patients treated with chemotherapy in BangladeshJapanese Journal of Clinical Oncology 2021; 51(4): 552 doi: 10.1093/jjco/hyaa228
37
Chenbo Ding, Junmin Luo, Longmei Li, Shanshan Li, Liwen Yang, Hongfei Pan, Qianyi Liu, Huan Qin, Chao Chen, Jihong Feng. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancerJournal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-015-0280-0
38
Weili Miao, Yinsheng Wang. Targeted Quantitative Kinome Analysis Identifies PRPS2 as a Promoter for Colorectal Cancer MetastasisJournal of Proteome Research 2019; 18(5): 2279 doi: 10.1021/acs.jproteome.9b00119
39
Urspeter Masche, Urs Strebel, Dominique H. Criblez, Urs Marbet, Markus M. Borner, Peter Buchmann, Richard Herrmann. Kolorektalkarzinompharma-kritik 2008; 30(3) doi: 10.37667/pk.2008.227
40
Terence C. Chua, Akshat Saxena, Winston Liauw, Francis Chu, David L. Morris. Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases – A systematic reviewEuropean Journal of Cancer 2012; 48(12): 1757 doi: 10.1016/j.ejca.2011.10.034
41
Albrecht Reichle. From Molecular to Modular Tumor Therapy2010; : 469 doi: 10.1007/978-90-481-9531-2_23
42
Young-Mi Lee, Saluja Kaduwal, Kug Hwa Lee, Jong-Chan Park, Woo-Jeong Jeong, Kang-Yell Choi. Sur8 mediates tumorigenesis and metastasis in colorectal cancerExperimental & Molecular Medicine 2016; 48(7): e249 doi: 10.1038/emm.2016.58
43
Tomasz Olesinski, Joanna Milewska, Malgorzata Symonides, Jakub Palucki, Andrzej Mróz, Andrzej Rutkowski. Pancreatic Metastases of Rectal Cancer—Case Report and Literature ReviewJournal of Gastrointestinal Cancer 2019; 50(2): 338 doi: 10.1007/s12029-017-0016-9
44
Leonie Harmse, Nadia Gangat, Carla Martins-Furness, Jean Dam, Charles B. de Koning. Copper-imidazo[1,2-a]pyridines induce intrinsic apoptosis and modulate the expression of mutated p53, haem-oxygenase-1 and apoptotic inhibitory proteins in HT-29 colorectal cancer cellsApoptosis 2019; 24(7-8): 623 doi: 10.1007/s10495-019-01547-7
45
Leo Chen, Caroline H. Speers, Winson Y. Cheung, John J. Spinelli, Hagen F. Kennecke. Impact of new cancer therapies on outpatient treatment delivery for colorectal cancer: A population‐based studyThe International Journal of Health Planning and Management 2021;  doi: 10.1002/hpm.3308